SomaLogic LogoSomaLogic boasts industry-leading reliability metrics that include sensitivity, specificity, and reproducibility. Learn More

The CU Boulder Connection

Professor Larry Gold (MCDB) founded SomaLogic, which pioneered the development of proteomics diagnostics and assays based on Gold’s SELEX technology. After going public in 2021, SomaLogic announced a merger with Standard BioTools in 2023.

Funding Status and Investment Opportunities

  • Industry: Biotech​, Genomics, Health and Wellness​, Therapeutics, Diagnostics
  • Funding Stage: Exit
  • Contact for Investment Inquiries: Standard Bio Tools Inc. (LAB)


  This page was last updated Nov. 13, 2023. Please contact us for corrections or updates